Specialist and experienced pricing and market access consultancy
We will develop and implement a successful launch strategy for your product.
We build payer focussed pricing and market access strategies to enable commercial success.
We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.
Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.
Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.
Individual solutions to suit you
We adapt our working style to reflect your needs
We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies
We react quickly and effectively to provide the best support possible
Surrogate Endpoints in HTA Decision-Making The need to stay ahead of competitors and offset losses f…
Read moreNICE’s Highly Specialised Technologies (HST) Programme offers a vital route for bringing ultra-rar…
Read moreOptimising evidence generation in trial design, while navigating regulatory and local payer requirem…
Read moreNegotiations between the Trump administration and pharmaceutical companies on lowering U.S…
Read moreAdvanced Therapy Medicinal Products (ATMPs) are offering transformative, and often life-saving, trea…
Read moreAdvanced Therapy Medicinal Products (ATMPs) are leading in healthcare innovation, providing potentia…
Read moreThe pricing benchmark has shifted faster than systems have adapted. In the UK, prices for one-time t…
Read moreSuccessfully navigating early payer scientific advice whether through Joint Scientific Consultations…
Read moreNICE has introduced important appraisal reforms for 2025 that will directly impact manufacturers pre…
Read more